-
Mashup Score: 5
The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 16Structural Heart Disease Program - 10 month(s) ago
Our team of cardiologists, heart surgeons and health care professionals at our Cherry Hill clinic work together to diagnose and treat structural heart disease.
Source: www.swedish.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Balloon-expandable valves deliver better short-term TAVR outcomes than self-expandable valves - 10 month(s) ago
A new meta-analysis, published in Frontiers in Cardiovascular Medicine, focused on data from nearly 3,000 patients with severe symptomatic aortic stenosis.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Balloon-expandable valves deliver better short-term TAVR outcomes than self-expandable valves - 10 month(s) ago
A new meta-analysis, published in Frontiers in Cardiovascular Medicine, focused on data from nearly 3,000 patients with severe symptomatic aortic stenosis.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Cardiologists shed new light on treating severe tricuspid regurgitation in high-risk heart failure patients - 11 month(s) ago
The 80-year-old patient was experiencing severe TR and already had a HeartMate II LVAD.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Satellite Program Guide | TVT 2023 - 11 month(s) ago
TVT 2023
Source: tvt2023.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Satellite Program Guide | TVT 2023 - 11 month(s) ago
TVT 2023
Source: tvt2023.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0TVT 2023 - 11 month(s) ago
The Most Anticipated Structural Heart Conference in the WorldWORLD-CLASS EDUCATIONHIGH-QUALITY TRAININGUNLIMITED NETWORKINGBREAKTHROUGH INNOVATIONTake advantage of discounted rates through June 5!The most anticipated structural heart conference in the world for more than a decade!Reflects the rapidly changing landscape of treating structural heart disease.Connects the brightest minds in the…
Source: tvt2023.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#TVT2023 is the official hashtag! Follow along for 4 days of world-class education & training in #structuralheart disease. https://t.co/KHjt42hXdl @bapat_savrtavr @BurkhoffMd @jgranadacrf @MayraGuerreroMD @hahn_rt @azeemlatib @MartyBLeon @TheDoctorMack @DeeDeeWangMD @triciarawh https://t.co/cpyN6ejxyB
-
-
Mashup Score: 0Fellows 2023 - 12 month(s) ago
It’s the annual CRF Interventional Cardiology Fellows Course — a hands-on education program covering key concepts in interventional cardiovascular medicine. Fellows, experienced physicians, and other members of the heart team will learn and refresh skills in all facets of coronary, structural, and endovascular interventions. View the course overview page to view who should attend, topics covered,…
Source: fellows2023.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Fellows 2023 - 12 month(s) ago
It’s the annual CRF Interventional Cardiology Fellows Course — a hands-on education program covering key concepts in interventional cardiovascular medicine. Fellows, experienced physicians, and other members of the heart team will learn and refresh skills in all facets of coronary, structural, and endovascular interventions. View the course overview page to view who should attend, topics covered,…
Source: fellows2023.crfconnect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years. #Cardiotwitter #SAVR #structuralheart #FDA #Trifecta #cardiacsurgery https://t.co/wx6YEOGi2C